Пошук по сайту
Авторизація
Логин:
Пароль:
Регистрация
Забыли свой пароль?
Періодика
Медична інформатика та інженерія
Партнери
Поиск информации по диагнозу / Med And Me Издательский дом ЗАСЛАВСКИЙ Zepter
Технічна підтримка

Американський ринок терапії еректильної дисфункції (U.S. Erectile Dysfunction Therapies Market)




Erectile dysfunction (ED) is estimated to affect more than 150 million men worldwide and the number of men with ED is expected to double by the year 2030. Although most cases are not reported, it is estimated that more than 30 million men affected in the United States (U.S).

While ED is more common in men older than age 65, most men older than age 40 experience occasional difficulty; it is estimated that more than 50% of men older than age 40 report periodic episodes of ED. Despite the high number of cases, impotence is greatly undertreated, with only an estimated 15% of men seeking help from a physician due to the fact that they view the condition as personal or embarrassing.

Since the launch of Pfizer’s oral drug Viagra (sildenafil) in 1998, there has been a considerable increase in public awareness of ED due to extensive marketing by leading drug manufacturers. As a result, the worldwide market for oral ED drugs has reached more than $4.2 billion.

The U.S. market for ED therapies (defined in this report as including prescription ED drugs and penile implants) is expected to continue stable, moderate growth over the next 5 years. Valued at more than $1.9 billion in 2010, the market is expected to increase at a healthy compound annual rate of 5.1%, with sales reaching more than $2.5 billion in 2015. The U.S. ED therapies market is expected to benefit not only from continued strong demand but from highly positive demographic trends, including a large, growing ED population, strong advertising/marketing, emerging next-generation ED therapies, launch of several lower cost generic drugs, and the continued adoption of improved penile implant systems.

This dynamic report from Medtech Insight includes analyses of products, markets, competitors, and emerging drugs, technology and opportunities. Covered topics in this report include erectile dysfunction drugs (existing and emerging oral and topical ED therapies), injectable and intraurethral agents, vacuum constriction devices, penile implants, and alternative treatments.

TABLE OF CONTENTS

EXECUTIVE SUMMARY

i. Causes and Prevention

ii. Diagnosis and Treatment

a. Oral Drug Therapy
b. Injectable and Intraurethral Drug Therapy
c. Vacuum Pump Therapy
d. Surgery/Penile Prosthesis Implantation

iii. Erectile Dysfunction Therapies Market

a. Drug Therapy
b. Penile Implants

iv. Methodology

Exhibit ES-1: Erectile Dysfunction Therapies, Combined Market Forecast, 2010-2015

1. CLINICAL OVERVIEW OF ERECTILE DYSFUNCTION

1.1 Causes and Prevention
1.2 Diagnosis and Treatment
1.2.1 Oral Drug Therapy
1.2.2 Injectable and Intraurethral Drug Therapy
1.2.3 Vacuum Pump Therapy
1.2.4 Surgery/Penile Prosthesis Implantation
1.3 Emerging Treatments

2. ERECTILE DYSFUNCTION THERAPIES MARKET

2.1 Drug Therapy
2.1.1 Oral Agents
2.1.1.1 Eli Lilly
2.1.1.2 Bayer HealthCare/Bayer
2.1.1.3 Pfizer
2.1.2 Injectable and Intraurethral Agents
2.1.2.1 Pfizer
2.1.2.2 Meda Pharmaceticals/Meda
2.1.3 Emerging Drugs
2.1.3.1 Oral Agents
2.1.3.1.1 Dong-A PharmTech/Dong-A Pharmaceutical
2.1.3.1.2 Palatin Technologies
2.1.3.1.3 Sanofi-aventis
2.1.3.1.4 SK Chemicals/SK Group
2.1.3.1.5 Vivus
2.1.3.1.6 Discontinued Clinical Development Programs
2.1.3.1.6.1 NitroMed
2.1.3.1.6.2 Novartis
2.1.3.1.6.3 Pfizer
2.1.3.2 Topical Agents
2.1.3.2.1 Futura Medical
2.1.3.2.2 Apricus Biosciences
2.1.4 Alternative Treatments
2.1.4.1 Pomegranate Extract
2.1.4.2 Testosterone Replacement Therapy
2.1.4.3 Yohimbine
2.1.4.4 Over-the-Counter Herbal Treatments
2.2 Penile Implants
2.2.1 Inflatable Implants
2.2.1.1 American Medical Systems/Endo Pharmaceuticals
2.2.1.2 Coloplast
2.2.2 Noninflatable Implants
2.2.2.1 American Medical Systems/Endo Pharmaceuticals
2.2.2.2 Coloplast
2.3 Vacuum Constriction Devices
2.3.1 Augusta Medical Systems
2.3.2 Timm Medical Technologies/Actient Pharmaceuticals
2.3.3 Post-T-Vac Medical
2.4 Market Analysis
2.4.1 Drug Therapy Market
2.4.1.1 Patient Volumes
2.4.1.2 Market Forecast
2.4.1.3 Competitive Analysis
2.4.2 Penile Implants Market
2.4.2.1 Procedure Volumes
2.4.2.2 Market Forecast
2.4.2.3 Competitive Analysis
Exhibit 2-1: Comparative Advantages and Disadvantages of Cialis, Levitra, STAXYN, and Viagra
Exhibit 2-2: Erectile Function Improvement Using Low-Dose Once-Daily Cialis
Exhibit 2-3: Erectile Function Improvement Using Low-Dose Once-Daily Cialisin Patients with Diabetes
Exhibit 2-4: Erectile Function Improvement Using Low-Dose Once-Daily Cialis in Patients with Controlled Hypertension or Cardiovascular Disease
Exhibit 2-5: Erection Confidence Improvement Using Low-Dose Once-Daily Cialis
Exhibit 2-6: Common Adverse Events Associated with the Use of Low-Dose Once-Daily Cialis
Exhibit 2-7: Erectile Function Improvement Using High-Dose Cialis
Exhibit 2-8: Erectile Function Improvement Using High-Dose Cialis in Patients with Diabetes
Exhibit 2-9: Erectile Function Improvement Using High-Dose Cialis in Patients with Controlled Hypertension or Cardiovascular Disease
Exhibit 2-10: Erection Confidence Improvement Using High-Dose Cialis
Exhibit 2-11: Common Adverse Events Associated with the Use of High-Dose Cialis
Exhibit 2-12: STAXYN Orally Disintegrating Tablets
Exhibit 2-13: Common Adverse Events Associated with the Use of STAXYN
Exhibit 2-14: Erectile Function Improvement Using Viagra, Pivotal Efficacy Results
Exhibit 2-15: Steps Involved in the Use of the MUSE Transurethral System
Exhibit 2-16: 2011, Selected Emerging Erectile Dysfunction Products
Exhibit 2-17: Benefits and Risks of Penile Implants
Exhibit 2-18: Advantages and Disadvantages of the AMS 700 Inflatable Penile Implant
Exhibit 2-19: The AMS 700 LGX Inflatable Penile Implant
Exhibit 2-20: Advantages and Disadvantages of the AMS Ambicor Inflatable Penile Implant
Exhibit 2-21: The Titan and Titan OTR Inflatable Penile Prostheses
Exhibit 2-22: The Genesis Flexible Rod Implant
Exhibit 2-23: The SOMAerectStf Vacuum Constriction Device
Exhibit 2-24: The Vitality OTC Vacuum Constriction Device
Exhibit 2-25: The Osbon ErecAid Vacuum Therapy System
Exhibit 2-26: The BOSS 2000-3 and MVP 700 Vacuum Constriction Devices
Exhibit 2-27: Erectile Dysfunction Drug Therapy, Patient Volumes Forecast, 2010-2015
Exhibit 2-28: Erectile Dysfunction Drug Therapy, Market Forecast, 2010-2015
Exhibit 2-29: 2010, Erectile Dysfunction Drug Therapy Market, Share by Supplier
Exhibit 2-30: Penile Prosthesis Implantation, Procedure Volumes Forecast, 2010-2015
Exhibit 2-31: Penile Implants, Market Forecast, 2010-2015
Exhibit 2-32: 2010, Penile Implants Market, Share by Supplier

3. COMPANY PROFILES

3.1 American Medical Systems, Inc./Endo Pharmaceuticals Holdings, Inc.
3.2 Apricus Biosciences, Inc.
3.3 Bayer AG
3.4 Futura Medical PLC
3.5 Eli Lilly and Company
3.6 Pfizer, Inc.
3.7 Reckitt Benckiser PLC
3.8 Vivus, Inc.
Publisher: Medtech Insight
Перекладач: translate.google.com
Американський ринок терапії еректильної дисфункції (U.S. Erectile Dysfunction Therapies Market)
Американський ринок терапії доброякісної гіперплазії передміхурової залози мінімально інвазивним методом (U.S. Minimally Invasive Benign Prostatic Hyperplasia Therapy Systems Market)
Американський ринок терапії нетримання сечі мінімально інвазивним методом (U.S. Minimally Invasive Urinary Incontinence Therapy Systems Market)
Американські ринки приладів загальної та ендоскопічної тазової хірургії (U.S. Markets for General and Pelvic Endoscopic Surgery Products)
Новини
22.06.2018  Антибіотики провокують появу каменів у нирках
22.06.2018  Дефіцит таурину - одна з причин безпліддя у чоловіків
22.06.2018  Ін'єкція нановолокон позбавить від атеросклерозу
22.06.2018  Дослідники розповіли, як можна перемогти старече недоумство
22.06.2018  Генетики пролили світло на те, як проказа захопила Європу
21.06.2018  Стимуляція мозку допомагає людям, які перенесли інсульт, ходити швидше
21.06.2018  Революція в медицині: вчені представили портативну МРТ-рукавичку
21.06.2018  Вірус гепатиту В виявився набагато старше, ніж вважалося
21.06.2018  Червоне вино приховує в собі справжній порятунок від раку простати
21.06.2018  Генетики дізналися, яким чином рак шкіри і якість засмаги пов'язані
20.06.2018  М'язову тканину можна навчити регенерації, довели експерименти
20.06.2018  Новий спосіб істотно спростить діагностику раку легенів
20.06.2018  Вчені розповіли, що допомагає дітям навчитися говорити
20.06.2018  Фахівцям вдалося впоратися з діабетом 1-го типу
20.06.2018  Препарат від остеопорозу може зупинити облисіння
19.06.2018  Унікальний випадок: під виглядом звичайного нежитю ховалося пошкодження мозку
19.06.2018  Фахівці наблизилися до перемоги над раком молочної залози
19.06.2018  Депресія і хвороба Альцгеймера пов'язані, заявляють неврологи
19.06.2018  Холестерин пов'язали з утворенням бляшок в мозку
19.06.2018  Медики розповіли, яких продуктів варто побоюватися людям з хворими нирками
HINARI
PubMed